|
Avoid AI Hype and Track Real Market Catalysts
Opening Recap Market Pulse: U.S. stocks edged within a tight band yesterday, shrugging off hawkish Fed chatter and ending largely flat. Tech names held ground
|
Opening Recap Market Pulse: U.S. stocks edged within a tight band yesterday, shrugging off hawkish Fed chatter and ending largely flat. Tech names held ground
Company Overview Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company focused on developing seralutinib, an inhaled therapy for pulmonary arterial hypertension (PAH) (ir.gossamerbio.com).
Opening Recap Market Pulse: Equities drifted Friday with tech sagging and value names barely moving, setting a lukewarm tone. Key Movers: China’s robot-hand unicorn Linkerbot
